Journal for ImmunoTherapy of Cancer Issues Research Articles in January 2024 Edition
February 02, 2024
February 02, 2024
MILWAUKEE, Wisconsin, Feb. 2 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its January 2024 edition (Vol. 12, Issue 1):
Basic tumor immunology:
* Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'
. . .
Basic tumor immunology:
* Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'
. . .